IGFBP3 and breast carcinoma: Therefore, despite a report that ΔNp63α can downregulate IGFBP-3 in squamous epithelial cell lines [41], this does not appear to be a likely mechanism of IGFBP-3 downregulation by DNA-damaging drugs in breast cancer cell lines.